Compounds > 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman
Page last updated: 2024-09-04

2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and Prostatic Neoplasms

2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azzi, A; Betti, M; Conte, C; Floridi, A; Galli, F; Pistilli, A; Rende, M; Stabile, AM1

Other Studies

1 other study(ies) available for 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and Prostatic Neoplasms

ArticleYear
The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation.
    Archives of biochemistry and biophysics, 2004, Mar-01, Volume: 423, Issue:1

    Topics: alpha-Tocopherol; Antioxidants; Cell Division; Chromans; Cyclin D1; Dose-Response Relationship, Drug; gamma-Tocopherol; Humans; Male; Propionates; Prostatic Neoplasms

2004